Pacific Booker Minerals Inc News Headlines

PBM 
$3.49
*  
0.40
10.28%
Get PBM Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading PBM now
Exchange: AMEX
Industry: Basic Industries
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Update: Pacific Booker Minerals' Permitting Process Gets Delayed
8/20/2014 7:35:00 AM - Seeking Alpha

Cigna Sees Brighter Future, Several Growth Initiatives - Analyst Blog
8/13/2014 6:10:00 PM - Zacks.com

BioScrip (BIOS) in Focus: Stock Adds 8.2% in Session - Tale of the Tape
8/8/2014 9:46:00 AM - Zacks.com

Will CVS Caremark (CVS) Surprise Earnings this Quarter? - Analyst Blog
8/4/2014 12:35:00 PM - Zacks.com

BioScrip's PBM Services Continue to Suffer - Analyst Blog
7/10/2014 7:10:00 PM - Zacks.com

Magellan Health Hits 52-Week High; Focused on Boosting Services - Analyst Blog
6/13/2014 10:30:00 AM - Zacks.com

Pacific Booker Minerals - An Intriguing But Sad Story
5/28/2014 11:30:00 AM - Seeking Alpha

CVS Caremark Misses Earnings on Weather Woes - Analyst Blog
5/2/2014 10:46:01 AM - Zacks.com

Will CVS Caremark (CVS) Beat Earnings This Quarter? - Analyst Blog
5/1/2014 6:30:01 PM - Zacks.com

After The Recent Stock Market Advances, Are Growth Stocks A Viable Option For Retirement Portfolios? Part 2
3/27/2014 6:55:00 PM - Seeking Alpha

CVS Caremark Corporation (CVS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
2/26/2014 8:00:01 AM - Zacks.com

BioScrip, Inc. (BIOS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
2/21/2014 8:00:01 AM - Zacks.com

CVS Reports A Strong Q4'13 Backed By Growth In Retail Pharmacy & Services
2/18/2014 2:35:23 PM - Trefis

CVS Caremark Beats on Q4 Earnings & Revs - Analyst Blog
2/11/2014 3:24:01 PM - Zacks.com

CVS Closes $2.1B Coram Buyout - Analyst Blog
1/21/2014 3:40:01 PM - Zacks.com

Stocks For 2014: Something For Everyone: Part 1
1/10/2014 4:38:28 PM - SeekingAlpha

Stocks For 2014: Something For Everyone: Part 1
1/10/2014 4:13:00 PM - Seeking Alpha

CVS Caremark Slips to Hold - Analyst Blog
1/2/2014 6:25:01 PM - Zacks.com

CVS Unveils FY14 Outlook, Growth Plan - Analyst Blog
12/19/2013 6:17:16 PM - Zacks.com

Express Scripts Holding Company (ESRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/13/2013 8:00:01 AM - Zacks.com

Shares Rise as CVS Plans to Aquire Coram - Analyst Blog
11/29/2013 5:06:22 PM - Zacks.com

CVS Tops Earnings, Ups Guidance - Analyst Blog
11/5/2013 10:29:01 AM - Zacks.com

The #1 Stock To Benefit From Obamacare
10/4/2013 3:31:38 PM - StreetAuthority

CVS Unit's Clinic Services Enter Hawaii. - Analyst Blog
9/27/2013 6:33:34 PM - Zacks.com

CTRX Slumps as WAG Opts for Private Health Exchange - Analyst Blog
9/19/2013 3:19:48 PM - Zacks.com